当前位置:首页 - 行情中心 - 恩华药业(002262) - 财务分析 - 现金流量表

恩华药业

(002262)

  

流通市值:170.77亿  总市值:196.25亿
流通股本:8.84亿   总股本:10.16亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,500,521,240.716,358,917,423.444,856,768,608.143,139,587,953.99
  收到的税费返还161,981.99655,090.72382,653.19370,401.75
  收到其他与经营活动有关的现金15,488,547.6873,984,119.8871,416,256.2640,530,139.77
  经营活动现金流入小计1,516,171,770.386,433,556,634.044,928,567,517.593,180,488,495.51
  购买商品、接受劳务支付的现金371,185,401.931,537,516,201.541,138,791,461.72832,410,420.4
  支付给职工以及为职工支付的现金259,689,706.71,142,008,395.51819,115,801.87477,274,732.84
  支付的各项税费198,435,011.44750,384,346.82560,502,997.54383,546,004
  支付其他与经营活动有关的现金529,032,021.431,925,257,933.341,499,010,699.51992,434,138.95
  经营活动现金流出小计1,358,342,141.55,355,166,877.214,017,420,960.642,685,665,296.19
  经营活动产生的现金流量净额157,829,628.881,078,389,756.83911,146,556.95494,823,199.32
二、投资活动产生的现金流量:
  取得投资收益收到的现金12,205,819.7446,367,997.138,124,521.1828,616,017.36
  处置固定资产、无形资产和其他长期资产收回的现金净额9,625339,238.24146,482.462,948.4
  收到的其他与投资活动有关的现金1,579,000,0006,817,000,0005,822,000,0004,388,000,000
  投资活动现金流入小计1,591,215,444.746,863,707,235.345,860,271,003.584,416,678,965.76
  购建固定资产、无形资产和其他长期资产支付的现金80,135,996.94437,407,150.19232,632,606.43151,681,742.53
  投资支付的现金-25,158,70025,158,70025,158,700
  取得子公司及其他营业单位支付的现金-77,95043,00043,000
  支付其他与投资活动有关的现金1,716,000,0006,963,000,0005,632,000,0003,940,000,000
  投资活动现金流出小计1,796,135,996.947,425,643,800.195,889,834,306.434,116,883,442.53
  投资活动产生的现金流量净额-204,920,552.2-561,936,564.85-29,563,302.85299,795,523.23
三、筹资活动产生的现金流量:
  取得借款收到的现金61,000,00030,000,00040,000,00040,000,000
  筹资活动现金流入小计61,000,00030,000,00040,000,00040,000,000
  偿还债务支付的现金30,000,00015,000,00055,000,00015,000,000
  分配股利、利润或偿付利息支付的现金-366,205,270.12367,016,667.36366,805,667.35
  支付其他与筹资活动有关的现金8,126,739.7134,892,430.0728,060,993.6815,627,976.73
  筹资活动现金流出小计38,126,739.71416,097,700.19450,077,661.04397,433,644.08
  筹资活动产生的现金流量净额22,873,260.29-386,097,700.19-410,077,661.04-357,433,644.08
四、汇率变动对现金及现金等价物的影响668,615.1-1,036,094.54222,198.59524,324.56
五、现金及现金等价物净增加额-23,549,047.93129,319,397.25471,727,791.65437,709,403.03
  加:期初现金及现金等价物余额1,342,781,677.221,213,462,279.971,213,462,279.971,213,462,279.97
  期末现金及现金等价物余额1,319,232,629.291,342,781,677.221,685,190,071.621,651,171,683
补充资料:
  净利润-1,054,901,758.25-700,054,285.99
  资产减值准备-39,684,627.5-22,034,891.47
  固定资产和投资性房地产折旧-146,009,287.69-71,819,044.68
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-146,009,287.69-71,819,044.68
  无形资产摊销-23,747,209-11,202,953.49
  长期待摊费用摊销-69,117,388.75-35,058,245.07
  处置固定资产、无形资产和其他长期资产的损失--165,788.21--41,856.14
  固定资产报废损失-835,383.26-290,590.89
  财务费用-3,474,946.8-720,798.92
  投资损失--61,159,905.52--32,479,568.44
  递延所得税--18,620,207.2--12,105,683.84
  其中:递延所得税资产减少--18,509,186.79--11,994,663.43
    递延所得税负债增加--111,020.41--111,020.41
  存货的减少--125,892,732.07--88,128,921.13
  经营性应收项目的减少--219,396,623.23--333,723,230.86
  经营性应付项目的增加-135,417,226.32-67,665,567.69
  其他-2,632,565.88-37,274,958
  现金的期末余额-1,342,781,677.22-1,651,171,683
  减:现金的期初余额-1,213,462,279.97-1,213,462,279.97
  现金及现金等价物的净增加额-129,319,397.25-437,709,403.03
公告日期2026-04-182026-04-182025-10-252025-07-30
审计意见(境内)标准无保留意见
TOP↑